Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
Launched by BOSTON CHILDREN'S HOSPITAL · Oct 21, 2020
Trial Information
Current as of July 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how children with congenital heart disease (CHD) handle non-cardiac surgeries and the health care resources needed for their care. Congenital heart disease is a condition that affects the structure of the heart and is found in about 6 out of every 1,000 newborns in the U.S. As medical advances have improved survival rates, many of these children may also need other types of surgeries as they grow. The goal of this study is to gather detailed information to better understand the risks these children face during non-cardiac procedures and to identify how health care systems can best support them.
To be eligible for this trial, participants must be children aged from birth up to 21 years who have been diagnosed with congenital heart disease and are scheduled for a non-cardiac procedure, whether it’s a surgery or another type of treatment. Unfortunately, children who are having heart-related surgeries or specific heart tests won’t be included. Families participating in the trial can expect to contribute to a larger understanding of how to improve care for children with CHD, which could ultimately lead to better outcomes for future patients. The study aims to create a collaborative database that captures important details about their health care experiences.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Males or females ages birth to 21 years.
- • 2. Patients diagnosed with congenital heart disease
- • 3. Patients undergoing a noncardiac procedure (surgical or nonsurgical)
- Exclusion Criteria:
- • 1. Patients with congenial heart disease undergoing a cardiac surgical procedure including pacemakers.
- • 2. Patients with congenital heart disease undergoing a catheterization(diagnostic or interventional) or an electrophysiology study
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Philadelphia, Pennsylvania, United States
Houston, Texas, United States
Nashville, Tennessee, United States
Boston, Massachusetts, United States
Norfolk, Virginia, United States
Minneapolis, Minnesota, United States
Washington, District Of Columbia, United States
Toronto, Ontario, Canada
Atlanta, Georgia, United States
Patients applied
Trial Officials
Viviane Nasr, MD
Principal Investigator
Boston Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials